TG Therapeutics Inc

TG Therapeutics Inc

TGTX · NASDAQ
TGTX · NASDAQ
60.40
USD-0.02-0.04%

Latest News

    SeekingAlpha

    TG Therapeutics gains amid takeover speculation

      @MarketRebels
      MarketRebels

      STARTS NOW! Rebels Edge 1pm $VXX UOA 👀 $BAC $WFC $TGTX $CLSK $TCOM 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarian NFL: Mike Tomlin Steps Down Amazing career, is it over?? Breakdown Saturday games today Who wins and why?? https://t.co/P1BlsYuJF0

        SeekingAlpha

        TG Therapeutics signs manufacturing supply agreement with FUJIFILM Diosynth Biotechnologies

          @MarketRebels
          MarketRebels

          STARTS NOW! Rebel's Edge 🏴‍☠️ 1pm Line up Jackson Hole Symposium insights into future monetary policy. $AMD $ZIM $TGTX $XPEV Sports 🏈 @petenajarian NCAAFootball is back Saturday from Dublin, Fla St v Georgia Tech NFL: QB- Young guns 6 of the 1st 12 picks who stands out? https://t.co/m3sQfshJZb

            @eWhispers
            eWhispers

            Last week was the busiest for S&P 500 companies reporting #earnings, but this is the week that counts with 1,200 companies set to report and $IWM in focus. https://t.co/oMi4gKp1GN ... oh, and $AAPL $SPY $STNG $SMCI $ALX $TGTX $SBT $ACMR $FUBO $WING $MSTR $CHGG $CEIX $SJW… https://t.co/VnxHiKbVM4

              @Reuters
              Reuters

              U.S. FDA approves TG Therapeutics' multiple sclerosis drug; shares surge https://t.co/jHTcQsvZjO https://t.co/XCYuLacaNZ

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              60.40USD
              62.20USD

              52 Week Range

              26.76USD
              63.60USD

              Market Cap

              9.37BUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US88322Q1085

              CUSIP

              048785109

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              21.80

              PEG Ratio

              1.61

              Book Value

              4.26

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              2.75

              Wall Street Target Price

              69.71

              EPS Estimate Current Year

              0.95

              EPS Estimate Next Year

              2.71

              EPS Estimate Current Quarter

              0.4386

              EPS Estimate Next Quarter

              0.4346

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              799,536,000

              Gross Profit TTM

              658,596,992

              EBITDA

              136,451,008

              Profit Margin

              55.22%

              Return On Assets TTM

              7.28%

              Return On Equity TTM

              100.28%

              Revenue Per Share TTM

              5.61

              Qtly Revenue Growth YOY

              70.30%

              Diluted Eps TTM

              2.75

              Qtly Earnings Growth YOY

              -70.60%

              Valuation

              Trailing PE

              21.80

              Forward PE

              28

              Price Sales TTM

              11.4784

              Price Book MRQ

              15.5024

              Enterprise Value Revenue

              11

              Enterprise Value EBITDA

              68

              Peers analysis

              • argenx NV ADR
                ARGXargenx NV ADR

                903.08

                3.20%
              • Moderna Inc
                MRNAModerna Inc

                227.40

                2.97%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                965.00

                0.55%
              • UCB SA
                UCBJFUCB SA

                314.92

                0.35%
              • argenx SE
                ARGNFargenx SE

                900.30

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                139.16

                0.00%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                528.21

                -4.77%
              • Be
                ONCBeiGene, Ltd.

                355.10

                -2.26%
              • CSL Ltd
                CSLLYCSL Ltd

                34.64

                -2.01%
              • UCB SA ADR
                UCBJYUCB SA ADR

                153.70

                -1.47%

              FAQs

              What is TG Therapeutics stock price today?

              What is TG Therapeutics stock ticker?

              Is TGTX stock price going up?

              What is the analyst recommendation for TGTX?

              What is TGTX market cap?

              Does TGTX release financial reports?

              When is TGTX next earnings date?

              What were TGTX Earnings for the last quarter?

              What was TGTX Revenue for the last quarter?

              What was TGTX Net Income for the last quarter?

              Does TGTX pay dividends?

              How many employees does TGTX have?

              What is TGTX EBITDA?

              How to buy TGTX stocks?

              Should I invest in TGTX stock?